Radcliffe Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Radcliffe Capital Management’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-641,462	Closed	-$6.63M	–	494
2023 Q2	$6.63M	Sell	641,462 -55,493	-8%	-$568K	0.56%	42
2023 Q1	$7.06M	Buy	696,955 +9,155	+1%	+$92.4K	0.44%	56
2022 Q4	$6.84M	Buy	687,800 +85,000	+14%	+$840K	0.22%	117
2022 Q3	$5.88M	Hold	602,800	–	–	0.14%	218
2022 Q2	$5.85M	Hold	602,800	–	–	0.14%	214
2022 Q1	$5.85M	Buy	602,800 +2,800	+0.5%	+$27.1K	0.14%	174
2021 Q4	$5.8M	Hold	600,000	–	–	0.17%	129
2021 Q3	$5.81M	Buy	+600,000	New	+$5.85M	0.19%	101

Other funds holding NKGN

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $382M AUM 31.69% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.2B AUM 23.27% 1-Year Est. Return

Mint Tower Capital Management Amsterdam, Netherlands $1.08B AUM 19.06% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return